Publications by authors named "S Saqrane"

In the last few decades, pharmaceuticals, credited with saving millions of lives, have emerged as a new class of environmental contaminants. These compounds can have both chronic and acute harmful effects on aquatic ecosystems and consequently on human health. Therefore, there is an urgent need for the development of extremely sensitive, portable, and low-cost devices to perform analysis.

View Article and Find Full Text PDF

The objective of this work is to study the toxicological effect of the imidacloprid (IMD) on common bean plants (Phaseolus vulgaris L) when used at high doses and its quantification by electrochemical method. Common bean plants were exposed to increasing concentrations of IMD and the different plant tissues were subjected to various analyses. The IMD detection in different tissues of the bean plant was performed after extraction on the metallic silver electrode using square wave voltammetry.

View Article and Find Full Text PDF

Flubendiamide (FBD) is the first commercially available phthalic acid diamide that targets ryanodine receptors (RyRs) in insects, which play a major role in lepidoptera control. However, excessive use of FBD can influence the quality of treated products leading to toxic effects on human health. The availability of rapid and convenient methods for evaluating FBD amount in the environment is necessary.

View Article and Find Full Text PDF

Some bacteria have developed resistance to antibiotics that were once commonly used to treat them. Moreover, this resistance has become more and more massive and worrying. During this work, we succeeded in synthesizing "metal-antibiotic" complexes, combining as a ligand for the metals of Cu (II), Zn (II) and Fe (III).

View Article and Find Full Text PDF

The management of SARS-CoV-2 has not yet been clearly determined and is based on potential therapies evaluated during the SARS-CoV and MERS-CoV outbreaks. An emerging potential therapeutic approach currently being evaluated in numerous clinical trials is the remdesivir agent, which acts on COVID-19 by interfering with key steps in the virus replication cycle. It is considered a therapeutic option to be evaluated against COVID-19, based on data on its in vitro and in vivo activity against MERS-CoV and SARS-CoV coronaviruses.

View Article and Find Full Text PDF